|
Real-time Estimate
Cboe BZX
11:28:29 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 33.08 USD | -0.99% |
|
-6.60% | -7.24% |
| 09-02 | Cogent Biosciences Enters Commercial Supply Agreement With Hovione FarmaCiencia | MT |
| 08-31 | Cogent Biosciences Insider Sold Shares Worth $1,689,493, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.8B | - | - | - | - | - |
| 66.93B | |||||
| 61.97B | |||||
| 28.26B | - | ||||
| 24.59B | |||||
| 24.3B | - |
Select your edition
All financial news and data tailored to specific country editions
